Massachusetts Financial Services CO Bridge Bio Pharma, Inc. Transaction History
Massachusetts Financial Services CO
- $314 Billion
- Q2 2024
A detailed history of Massachusetts Financial Services CO transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 598,263 shares of BBIO stock, worth $14.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
598,263
Previous 379,006
57.85%
Holding current value
$14.9 Million
Previous $11.7 Million
29.32%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$775 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$627 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$351 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$310 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$151 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.7B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...